The tobacco industry, researchers, and ethical access to UK Biobank: using the public interest and public good
- PMID: 25122018
- PMCID: PMC4167123
- DOI: 10.2105/AJPH.2014.302138
The tobacco industry, researchers, and ethical access to UK Biobank: using the public interest and public good
Abstract
We have asked whether the strategic purpose of the tobacco industry is something that a public resource, such as UK Biobank, should support. Tobacco industry health research has been known to work irreconcilably with the purposes of such institutions, which can be surmised as for the public good and defined to improve the provision, diagnosis, and treatment of illness and the promotion of health throughout society. We have isolated possible conflicts of interest that underlie vested research agendas of the tobacco industry and that may extend to tobacco industry-funded researchers. With respect to research, we find that the tobacco industry is entirely at odds with the purposes of public biobanking.
Comment in
-
Is science public health's BFF?Am J Public Health. 2014 Oct;104(10):1798. doi: 10.2105/AJPH.2014.302209. Epub 2014 Aug 14. Am J Public Health. 2014. PMID: 25122012 Free PMC article. No abstract available.
Similar articles
-
Is science public health's BFF?Am J Public Health. 2014 Oct;104(10):1798. doi: 10.2105/AJPH.2014.302209. Epub 2014 Aug 14. Am J Public Health. 2014. PMID: 25122012 Free PMC article. No abstract available.
-
Conflicts of interest in tobacco industry-funded research.Lancet Oncol. 2021 Jun;22(6):758. doi: 10.1016/S1470-2045(21)00281-3. Epub 2021 May 6. Lancet Oncol. 2021. PMID: 33965060 No abstract available.
-
Conflicts of interest in e-cigarette research: A public good and public interest perspective.Bioethics. 2020 Jan;34(1):114-122. doi: 10.1111/bioe.12619. Epub 2019 Aug 25. Bioethics. 2020. PMID: 31448428
-
Human biological sample biobanking to support tissue biomarkers in pharmaceutical research and development.Methods. 2014 Nov;70(1):3-11. doi: 10.1016/j.ymeth.2014.01.014. Epub 2014 Jan 30. Methods. 2014. PMID: 24486552 Review.
-
Tobacco industry manipulation of research.Public Health Rep. 2005 Mar-Apr;120(2):200-8. doi: 10.1177/003335490512000215. Public Health Rep. 2005. PMID: 15842123 Free PMC article. Review. No abstract available.
Cited by
-
Can a good tree bring forth evil fruit? The funding of medical research by industry.Br Med Bull. 2016 Jun;118(1):5-15. doi: 10.1093/bmb/ldw014. Epub 2016 May 5. Br Med Bull. 2016. PMID: 27151955 Free PMC article. Review.
-
Models of biobanks and implications for reproductive health innovation.Monash Bioeth Rev. 2015 Dec;33(4):238-57. doi: 10.1007/s40592-015-0042-y. Monash Bioeth Rev. 2015. PMID: 26670686 Clinical Trial.
References
-
- UK Biobank Ethics and Governance Council. UK Biobank ethics and governance framework, version 3.0. 2007. Available at: www.ukbiobank.ac.uk/wp-content/uploads/2011/05/EGF20082.pdf. Accessed February 13, 2014.
-
- Capps B. Defining variables of access to UK Biobank: the public interest and the public good. Law Innovation Tech. 2013;5(1):113–139.
-
- UK Biobank Coordinating Centre. Access procedures: application and review procedures for access to the UK Biobank resource, version 1.0. 2011. Available at: http://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/Access_Procedures_.... Accessed February 13, 2014.
-
- UK Biobank Coordinating Centre. UK Biobank FAQs. 2014. Available at: http://www.ukbiobank.ac.uk/all-faqs. Accessed February 13, 2014.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources